Societe Generale Effekten (SCO2S3)

ITS STARTING TO LOOK SCARY BRO.MAYBE IT WILL KEEP GOING DOWN.BIG BLOCKS ON THE OFFERS.NEXT STOP .015 AND THEN .0135 AND .0117,AND .009S AND .0077S.LETS SEE ALL THESE PRICES IMMEDIATELY BEFORE THE Q2 REPORT IN AUGUST 15TH DUE DAY.WE GOT 6 WEEKS BEFORE THE REPORT.THAT IS A HECK OF A LONG TIME.THIS TH

Any guesses when canna gets of the EM and price target? Tia for your opinions.

I see!!!

I think there will be a lot selling between where we stand today and roughly the 5 dollar share price, when approval hits. A lot of us have been in this stock for multiple years and are far in the red. Many of us are approaching retirement or are already in retirement. Many of us, myself included

They are also heavily reliant on Dupixent and the COM patent expires in early 2031 so not that far off
Dupixent may also lose share to long acting injectables and orals targeting that pathway

I'll never compain when the share price increases but I'm surprised we didn't see more of a bump. I own shares through TSX and can confrim they did not change. Maybe tomorrow will be another trend upwards. Added more shares today. With this latest EA approval this is a bargain buy right now!

This text is a standard initial rule in a patent lawsuit. It means the person or company suing (the plaintiff) must formally list the exact products violating their patents, explain how they calculate their financial demands, and share the official government records of how their patent was approved

MRNJ>>>-99.92%

MRNJ
INVESTORShub
-99.92%
https://investorshub.advfn.com/stock-market/USOTC/metatron-id-MRNJ/historical

MRNJ>>>-99.92%

MRNJ
INVESTORShub
-99.92%

hold steady. longs gonna win here imo

It is now July 1, 2026, this stock’s price situation has not improved but done just the opposite, gone way down from the year it was at $1.50, and down approximately 50% from it’s last low high of $.42, now that is not a sign of a company in it’s best shape ever. This is not, or will it ever be in

https://www.sec.gov/submit-tip-or-complaint

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -33 (Extreme Bearish). Extreme Overdue: 60 min (60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/1/jwcnf1_Status_Report.PNG

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -33 (Extreme Bearish). Extreme Overdue: 60 min (60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/1/jwcnf1_Status_Report.PNG

Anything under the ATH is a great buy IMO.

Anyone else agree like and share.

Last time I mowed was June 7th. So it’s been a minute 

Evidently when you put everything in caps it makes you more right.

The life-changing mental health treatment most Americans don’t know exists

https://www.usatoday.com/story/sponsor-story/acumen-usa250/2026/07/01/the-life-changing-mental-health-treatment-most-americans-dont-know-exists/90681643007/

July 1, 2026, 6:01 a.m. ET

Hi Neo, - I dont think I missed the point - we both are making a LOT of assumptions and you most important assumption is that common shareholders will not suffer dilution of any type - warrants - SPS - JPS Conversion. You get a valuation of $ 221 a share for FNMA and an implied valuation of FMCC o

BIEL UPDATE - HUGE - PROFITABLE
BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress

JEFFERSON, MD - June 30, 2026 (NEWMEDIAWIRE) - BioElectronics Corporation (https://www.bielcorp.com/) (OTC: BIEL), a developer of medical technology product

BIEL UPDATE - HUGE - PROFITABLE
BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress

JEFFERSON, MD - June 30, 2026 (NEWMEDIAWIRE) - BioElectronics Corporation (https://www.bielcorp.com/) (OTC: BIEL), a developer of medical technology product

Trump what are you talking about . He’s got nothing to with Opendoor.

Report #9 SPX Cycles 12 Month Range Forecast: July 2027 projections, current high & low for this month
The projected high range is based on the current year 60 min cycle average.
The projected low range is based on the 60 min cycle averages from 2011 to present

https://i

https://x.com/TechForce_X/status/2064922811408560324/video/1